BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34090711)

  • 1. Premature termination codon mutations in ABCA7 contribute to Alzheimer's disease risk in Belgian patients.
    Bossaerts L; Hens E; Hanseeuw B; Vandenberghe R; Cras P; De Deyn PP; Engelborghs S; Van Broeckhoven C;
    Neurobiol Aging; 2021 Oct; 106():307.e1-307.e7. PubMed ID: 34090711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease.
    De Roeck A; Van den Bossche T; van der Zee J; Verheijen J; De Coster W; Van Dongen J; Dillen L; Baradaran-Heravi Y; Heeman B; Sanchez-Valle R; Lladó A; Nacmias B; Sorbi S; Gelpi E; Grau-Rivera O; Gómez-Tortosa E; Pastor P; Ortega-Cubero S; Pastor MA; Graff C; Thonberg H; Benussi L; Ghidoni R; Binetti G; de Mendonça A; Martins M; Borroni B; Padovani A; Almeida MR; Santana I; Diehl-Schmid J; Alexopoulos P; Clarimon J; Lleó A; Fortea J; Tsolaki M; Koutroumani M; Matěj R; Rohan Z; De Deyn P; Engelborghs S; Cras P; Van Broeckhoven C; Sleegers K;
    Acta Neuropathol; 2017 Sep; 134(3):475-487. PubMed ID: 28447221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Cuyvers E; De Roeck A; Van den Bossche T; Van Cauwenberghe C; Bettens K; Vermeulen S; Mattheijssens M; Peeters K; Engelborghs S; Vandenbulcke M; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Sleegers K
    Lancet Neurol; 2015 Aug; 14(8):814-822. PubMed ID: 26141617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare missense mutations in ABCA7 might increase Alzheimer's disease risk by plasma membrane exclusion.
    Bossaerts L; Hendrickx Van de Craen E; Cacace R; Asselbergh B; Van Broeckhoven C
    Acta Neuropathol Commun; 2022 Mar; 10(1):43. PubMed ID: 35361255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics.
    De Roeck A; Van Broeckhoven C; Sleegers K
    Acta Neuropathol; 2019 Aug; 138(2):201-220. PubMed ID: 30903345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease.
    De Roeck A; Duchateau L; Van Dongen J; Cacace R; Bjerke M; Van den Bossche T; Cras P; Vandenberghe R; De Deyn PP; Engelborghs S; Van Broeckhoven C; Sleegers K;
    Acta Neuropathol; 2018 Jun; 135(6):827-837. PubMed ID: 29589097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response.
    Duchateau L; Küҫükali F; De Roeck A; Wittens MMJ; Temmerman J; Weets I; Timmers M; Engelborghs S; Bjerke M; Sleegers K
    Alzheimers Res Ther; 2023 Nov; 15(1):195. PubMed ID: 37946268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCA7 p.G215S as potential protective factor for Alzheimer's disease.
    Sassi C; Nalls MA; Ridge PG; Gibbs JR; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Clement N; Lord J; Turton J; Bras J; Almeida MR; ; Holstege H; Louwersheimer E; van der Flier WM; Scheltens P; Van Swieten JC; Santana I; Oliveira C; Morgan K; Powell JF; Kauwe JS; Cruchaga C; Goate AM; Singleton AB; Guerreiro R; Hardy J
    Neurobiol Aging; 2016 Oct; 46():235.e1-9. PubMed ID: 27289440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis of the Association between Variants in ABCA7 and Alzheimer's Disease.
    Ma FC; Wang HF; Cao XP; Tan CC; Tan L; Yu JT
    J Alzheimers Dis; 2018; 63(4):1261-1267. PubMed ID: 29782324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
    Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
    Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCA7-Associated Clinical Features and Molecular Mechanisms in Alzheimer's Disease.
    Qian XH; Chen SY; Liu XL; Tang HD
    Mol Neurobiol; 2023 Oct; 60(10):5548-5556. PubMed ID: 37322288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCA7 in Alzheimer's Disease.
    Zhao QF; Yu JT; Tan MS; Tan L
    Mol Neurobiol; 2015; 51(3):1008-16. PubMed ID: 24878767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ABC's of Alzheimer risk gene ABCA7.
    Duchateau L; Wawrzyniak N; Sleegers K
    Alzheimers Dement; 2024 May; 20(5):3629-3648. PubMed ID: 38556850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of the ABCA7 rs3752246 polymorphism in Alzheimer's disease.
    Fehér Á; Juhász A; Pákáski M; Janka Z; Kálmán J
    Psychiatry Res; 2019 Sep; 279():376-377. PubMed ID: 30717989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSEN2 and ABCA7 variants causing early-onset preclinical pathological changes in Alzheimer's disease: a case report and literature review.
    Gan J; Zhou H; Liu C; Fang L
    Neurol Sci; 2023 Jun; 44(6):1987-2001. PubMed ID: 36701017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ABCA7 in Human Health and in Alzheimer's Disease.
    Dib S; Pahnke J; Gosselet F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease.
    Yamazaki K; Yoshino Y; Mori T; Yoshida T; Ozaki Y; Sao T; Mori Y; Ochi S; Iga JI; Ueno SI
    J Alzheimers Dis; 2017; 57(1):171-181. PubMed ID: 28222527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Shanghai Aging Study.
    Xi J; Ding D; Zhao Q; Liang X; Zheng L; Guo Q; Hong Z; Fu H; Xu J; Xiao Q
    Curr Alzheimer Res; 2020; 17(2):185-195. PubMed ID: 32183673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCA7 rare variants and Alzheimer disease risk.
    Le Guennec K; Nicolas G; Quenez O; Charbonnier C; Wallon D; Bellenguez C; Grenier-Boley B; Rousseau S; Richard AC; Rovelet-Lecrux A; Bacq D; Garnier JG; Olaso R; Boland A; Meyer V; Deleuze JF; Amouyel P; Munter HM; Bourque G; Lathrop M; Frebourg T; Redon R; Letenneur L; Dartigues JF; Pasquier F; Rollin-Sillaire A; Génin E; Lambert JC; Hannequin D; Campion D;
    Neurology; 2016 Jun; 86(23):2134-7. PubMed ID: 27037229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ABCA7 loss-of-function variant in Alzheimer's disease: a replication study in European-Americans.
    Del-Aguila JL; Fernández MV; Jimenez J; Black K; Ma S; Deming Y; Carrell D; Saef B; ; Howells B; Budde J; Cruchaga C
    Alzheimers Res Ther; 2015 Dec; 7(1):73. PubMed ID: 26654793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.